Bcl-2 associated athanogene-1 overexpression in diffuse large B-cell lymphoma

Iranian Journal of Immunology

Volumn 5, Issue 2, 2008, Pages 124-129

  Ataollahi, Mohammadreza ^a   Salehi, Mansour ^b   Doostan, Iman ^b   Kabiri, Zahra ^b   Mohajeri, Mohammadreza ^b   Mahmoodi, Farzaneh ^b   Shokouhi, Raheleh ^b   Javan, Shadi ^b   Meshkibaf, Mohammad Hassan ^a   Miladpoor, Behnoosh ^a  

^a FASA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Apoptosis; BAG 1; DLBCL; Immunohistochemistry

Indexed keywords

BAG 1 PROTEIN;

ARTICLE; B CELL LYMPHOMA; CANCER SURVIVAL; CELL NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; HUMAN; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; LYMPH NODE; PATIENT SELECTION; PROTEIN EXPRESSION;

EID: 45349098115     PISSN: 17351383     EISSN: 1735367X     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Tzankov A, Pehrs AC, Zimpfer A, Ascani S, Lugli A, Pileri S et al. Prognostic significance of CD44 expression in diffuse large B cell lymphoma of activated and germinal centre B cell-like types: a tissue microarray analysis of 90 cases. J Clin Pathol. 2003; 56:747-52.
2. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol. 1984; 133:1710-5.
3. Leroy K, Haioun C, Lepage E, Le Metayer N, Berger F, Labouyrie E et al. p53 gene mutations are associated with poor survival in low and low-intermediate risk diffuse large B-cell lymphomas. Ann Oncol. 2002; 13:1108-15.
4. Sanchez E, Chacon I, Plaza MM, Munoz E, Cruz MA, Martinez B et al. Clinical outcome in diffuse large B-cell lymphoma is dependent on the relationship between different cell-cycle regulator proteins. J Clin Oncol. 1998; 16:1931-9.
5. Townsend PA, Cutress RI, Sharp A, Brimmell M, Packham G. BAG-1: a multifunctional regulator of cell growth and survival. Biochim Biophys Acta. 2003; 1603:83-98.
6. Townsend PA, Stephanou A, Packham G, Latchman DS. BAG-1: a multi-functional pro-survival molecule. Int J Biochem Cell Biol. 2005; 37:251-9.
7. Packham G, Brimmell M, Cleveland JL. Mammalian cells express two differently localized Bag-1 isoforms generated by alternative translation initiation. Biochem J. 1997; 328:807-13.
8. Takayama S, Krajewski S, Krajewska M, Kitada S, Zapata JM, Kochel K et al. Expression and location of Hsp70/Hsc-binding anti-apoptotic protein BAG-1 and its variants in normal tissues and tumor cell lines. Cancer Res. 1998; 58:3116-31.
9. Takayama S, Sato T, Krajewski S, Kochel K, Irie S, Millan JA et al. Cloning and functional analysis of BAG-1: a novel Bcl-2-binding protein with anti-cell death activity. Cell. 1995; 80:279-84.
10. Arhel NJ, Packham G, Townsend PA, Collard TJ, Zadeh AM, Sharp A et al. The retinoblastoma protein interacts with Bag-1 in human colonic adenoma and carcinoma derived cell lines. Int J Cancer. 2003; 106:364-71.
11. King FW, Wawrzynow A, Hohfeld J, Zylicz M. Co-chaperones Bag-1, Hop and Hsp40 regulate Hsc70 and Hsp90 interactions with wild-type or mutant p53. EMBO J. 2001; 20:6297-305.
12. Takayama S, Reed JC. Molecular chaperone targeting and regulation by BAG family proteins. Nat Cell Biol. 2001;3: 237-41.
13. Packham G, White EL, Eischen CM, Yang H, Parganas E, Ihle JN et al. Selective regulation of Bcl-XL by a Jak kinase-dependent pathway is bypassed in murine hematopoietic malignancies. Genes Dev. 1998;12:2475-87.
14. Sekiya M, Adachi M, Takayama S, Reed JC, Imai K. IFN-gamma upregulates anti-apoptotic gene expression and inhibits apoptosis in IL-3-dependent hematopoietic cells. Biochem Biophys Res Commun. 1997;;239:401-6.
15. Cutress RI, Townsend PA, Brimmell M, Bateman AC, Hague A, Packham G. BAG-1 expression and function in human cancer. Br J Cancer. 2002; 87:834-9.
16. Noguchi T, Takeno S, Shibata T, Fumoto S, Uchida Y, Yokoyama S et al. Nuclear BAG-1 expression is a biomarker of poor prognosis in esophageal squamous cell carcinoma. Dis Esophagus. 2003; 16:107-11.
17. Xiong J, Chen J, Chernenko G, Beck J, Liu H, Pater A et al. Antisense BAG-1 sensitizes HeLa cells to apoptosis by multiple pathways. Biochem Biophys Res Commun. 2003; 312:585-91.
18. Yang X, Pater A, Tang SC Cloning and characterization of the human BAG-1 gene promoter: upregulation by tumor-derived p53 mutants. Oncogene. 1999; 18:4546-53.
19. Sjostrom J, Blomqvist C, von Boguslawski K, Bengtsson NO, Mjaaland I, Malmstrom P et al. The predictive value of bcl-2, bax, bcl-xL, bag-1, fas, and fasL for chemotherapy response in advanced breast cancer. Clin Cancer Res. 2002; 8:811-6.
20. Turner BC, Krajewski S, Krajewska M, Takayama S, Gumbs AA, Carter D et al. BAG-1: a novel biomarker predicting long-term survival in early-stage breast cancer. J Clin Oncol. 2001; 19:992-1000.
21. Tang SC, Beck J, Murphy S, Chernenko G, Robb D, Watson P et al. BAG-1 expression correlates with Bcl-2, p53, differentiation, estrogen and progesterone receptors in invasive breast carcinoma. Breast Cancer Res Treat. 2004; 84:203-13.
22. Yamauchi H, Adachi M, Sakata K, Hareyama M, Satoh M, Himi T et al. Nuclear BAG-1 localization and the risk of recurrence after radiation therapy in laryngeal carcinomas. Cancer Lett. 2001; 165:103-10.
23. Barnes JD, Arhel NJ, Lee SS, Sharp A, Al Okail M, Packham G et al. Nuclear BAG-1 expression inhibits apoptosis in colorectal adenoma-derived epithelial cells. Apoptosis. 2005; 10:301-11.
24. Yang X, Hao Y, Ding Z, Pater A, Tang SC. Differential expression of antiapoptotic gene BAG-1 in human breast normal and cancer cell lines and tissues. Clin Cancer Res. 1999; 5:1816-22.
25. Xerri L, Devilard E, Bouabdallah R, Hassoun J, Chaperot L, Birg F et al. Quantitative analysis detects ubiquitous expression of apoptotic regulators in B cell non-Hodgkin's lymphomas. Leukemia. 1999; 13:1548-53.